KMTS
HealthcareKestra Medical Technologies, Ltd. Common Stock
Key Drivers
- Strong Liquidity
- Rising Debt
- Heavy Cash Burn
AIAI Summary
KMTS has evolved into a high-growth execution story, but at ~13x sales its 60% revenue growth and improving 56.5% gross margin must quickly translate into sharply lower cash burn and operating losses to avoid dilution or rising debt risk; investors should wait for sustained mid-50%+ margins and materially improved quarterly cash flow before underwriting the upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Rising Debt
- •Heavy Cash Burn
KMTS has ample liquidity but deteriorating net cash, persistent heavy losses, and negative free cash flow make its premium sales/book valuation highly dependent on asset value rather than operating turnaround.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Resistance rejection
- •Support test
KMTS remains bearish last month, with price below its average and needing to reclaim $25.64–$25.73 to improve momentum while $24.06 support remains critical.
Brief rebound from $22.85 to $25.18 failed at resistance
Sentiment & News
Key News Insights:
- •Raised revenue outlook
- •Wider-than-expected loss
- •Heavy cash burn
Kestra's strong revenue growth and raised outlook are offset by wider losses, heavy cash burn, and a sharp post-earnings share decline.
Near-term sentiment remains pressured despite encouraging growth and margin-expansion potential
Similar Companies in Healthcare
Other companies in the same sector with AI ratings